GMPs

Sun Pharma, Ranbaxy Face U.S. Recalls

Indian generics makers Sun Pharma and Ranbaxy are both facing individual Class II U.S. recalls related to product mixups. Both recalls were included in the FDA’s March 5 enforcement report. Read More